Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2014 Pharmacodynamics in Healthy Japanese and Caucasian Subjects
NCT00280384Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2006
- Primary completion
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type b in cervical dystonia, sponsored by Eisai Co., Ltd.. Started Jan 2006; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
cervical dystonia
Beyond the preview
Go deeper on NCT00280384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280384.